Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

Donald Trump & Replimune Group

5 shared events · Importance 3 · Last updated Aug 26, 2026

Importance
3
Shared Events
5
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
49
Regulatory
Donald Trump: Trump nominated Overton and his administration is driving the FDA restructuring, reflecting his influence on regulatory policy.
Replimune Group: Replimune Group received accelerated approval for its melanoma drug after a regulatory battle, benefiting from FDA decisions.
Aug 25, 2026 · 6 articles
45
Domestic
Donald Trump: President Trump nominated Overton, reinforcing his administration's health policy direction. His influence over the FDA's regulatory approach is central to the event.
Replimune Group: Replimune Group, a biotech, had disagreements with the FDA under Makary. Overton's nomination may affect rare-disease drug approvals.
Aug 19, 2026 · 101 articles
24
Tech
Donald Trump: The Trump administration has been critical of mRNA technology, and its policies could affect regulatory approval and public acceptance of the vaccine. However, the trial's success may temper some opposition.
Replimune Group: Replimune recently received FDA approval for its melanoma therapy Tudriqev. The success of the Moderna-Merck vaccine may increase competition but also validates the broader field of cancer immunotherapy.
Aug 19, 2026 · 126 articles
17
Regulatory
Donald Trump: As President, Trump's administration has overseen vaccine policy changes and FDA leadership, influencing the regulatory climate.
Replimune Group: Replimune Group was mentioned in context of FDA scrutiny under Makary, but is not directly affected by this approval.
Aug 05, 2026 · 105 articles
0
Domestic
Replimune Group: Replimune Group>>> experienced rejection of its melanoma therapy by the United States — Food and Drug Administration>>> under Marty Makary>>>'s leadership, leading to public criticism and contributing to the pressure for his ouster.
May 08, 2026 · 114 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Donald Trump and Replimune Group interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.